Elevated AFP levels are associated with larger tumours, bilobar involvement, portal vein invasion, poorly differentiated histology and decreased median survival.3 Measurement of AFP level has been incorporated into some HCC prognostic scoring systems.4,5 While high levels of AFP are recognised as a poor prognostic factor, the utility of AFP response or progression during anticancer treatment is still unclear. The gene discussed is AFP; the disease is neoplasm.